Breaking News Instant updates and real-time market news.

CPB

Campbell Soup

$42.63

0.64 (1.52%)

14:45
08/09/18
08/09
14:45
08/09/18
14:45

Third Point confirms 5.7% Campbell stake, says sale 'only justifiable outcome'

Third Point confirmed in a regulatory filing that its funds expended an aggregate of approximately $686,442,376.90 of their own investment capital to acquire 17M shares of Campbell Soup stock, representing a stake of 5.65%. In the filing, Third Point states in part: "The Reporting Persons acquired most of their Capital Stock following the Issuer's disastrous fiscal 3q18 earnings report and the unexpected departure of the Issuer's Chief Executive Officer Denise Morrison. The Reporting Persons believe that the subsequently announced strategic review, if conducted properly, will create significant value for the Issuer's shareholders...The Reporting Persons understand from our conversations with the Issuer's Interim Chief Executive Officer, Keith R. McLoughlin, and the Issuer's public statements that all options, including a sale, are being evaluated in the ongoing strategic review. The Reporting Persons are encouraged by recent press reports suggesting that a sale process is already underway. Given the significant obstacles facing the Issuer, the Reporting Persons believe that the only justifiable outcome of the strategic review is for the Issuer to be sold to a strategic buyer...The Reporting Persons insist that the Issuer's Board conduct a rigorous strategic review that results in the best outcome for investors. The Issuer's Board must weigh the value of the Issuer to a strategic buyer today versus the present value of alternate "go it alone" scenarios, adjusted for execution risk. The Group will continue to advocate strongly for shareholders during the strategic review and may seek Board representation if we conclude that the Issuer's Board failed to discharge its fiduciary duty."

CPB Campbell Soup
$42.63

0.64 (1.52%)

06/26/18
SBSH
06/26/18
NO CHANGE
SBSH
Buy
Citi sees 'low probability' of Campbell Soup putting itself up for sale
After the New York Post said that Kraft Heinz (KHC) would be interested in acquiring Campbell Soup (CPB), Citi analyst David Driscoll said he thinks Campbell deciding to sell itself entirely is a "low probability event" and he believes the company is more likely to pursue divestitures. However, in the low probability scenario that Campbell is put up for sale, his "unconventional pick" for a buyer is Conagra (CAG) rather than Kraft, Driscoll added. He maintains a Buy rating on Campbell Soup shares, which closed up 9% at $42.23 yesterday following the Post's report.
06/26/18
BERN
06/26/18
NO CHANGE
BERN
Kraft Heinz buying Campbell will not solve 'perception problem,' says Bernstein
Bernstein analyst Alexia Howard note that The New York Post reported that Kraft Heinz (KHC) would be interested in buying Campbell Soup (CPB) should the company decide to put itself up for sale. Based on her accretion analysis, the analyst believes the deal could be slightly EPS dilutive before synergies, and 13%-22% accretive for Kraft Heinz after incorporating cost synergies. Despite the potential EPS accretion, Kraft Heinz buying Campbell Soup will not solve the company's "perception problem," Howard contends, adding that there seems to be a belief that the boards of potential target companies may be unwilling to sell to Kraft Heinz because of the company's poor track record of managing the top line, particularly in the U.S.
06/25/18
STFL
06/25/18
NO CHANGE
STFL
Hold
Campbell more likely to focus on divestitures than outright sale, says Stifel
Following a New York Post report suggested that Kraft Heinz (KHC) is interested in purchasing Campbell Soup (CPB), Stifel analyst Christopher Growe stated in a note to investors entitled "Mmm, Mmm...Maybe" that he believes Campbell will not pursue an outright sale and will instead focus on small divestitures in front of its deal for Snyder's Lance. While an acquisition of Campbell Soup could bring significant EPS accretion to Kraft Heinz, Growe also believes it would have a negative impact on Kraft's multiple as it would perpetuate the negative perceptions of the company's growth rate, he tells investors. He keeps a Buy rating on Kraft Heinz shares and a Hold rating on Campbell Soup.
06/25/18
JPMS
06/25/18
NO CHANGE
Target $67
JPMS
Overweight
Kraft, Campbell deal may not occur, but 'in the end, money talks,' says JPMorgan
On Friday night, The New York Post reported that Kraft Heinz (KHC) "is very much interested in buying Campbell (CPB) -- and believes the soup maker's management will start a sales process soon." JPMorgan analyst Ken Goldman told investors in a research note that there are arguments for a potential deal, including the use of Campbell as a "stepping stone" to a larger deal down the road, ownership of the Campbell Soup label, but arguments against it include that Campbell "does not seem to fit" in Kraft's desire to buy growth-type assets that have international expansion potential. Goldman says he "would be surprised" if Kraft wanted Campbell, as it does not solve Kraft's growth problem and is facing "numerous" internal challenges, and does not see a deal occurring. However, Goldman notes that "in the end, money talks," and a deal cannot be dismissed out of hand. Goldman has an Overweight rating and $67 price target on Kraft Heinz shares.

TODAY'S FREE FLY STORIES

TIF

Tiffany

$126.28

0.7 (0.56%)

16:55
09/25/18
09/25
16:55
09/25/18
16:55
Hot Stocks
Tiffany director Fish sells 6,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

ABBV

AbbVie

$93.78

0.34 (0.36%)

16:52
09/25/18
09/25
16:52
09/25/18
16:52
Hot Stocks
AbbVie approved for VENCLEXTAR/Rituximab leukemia treatment in Canada »

AbbVie announced Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

CONE

CyrusOne

$64.65

-0.6 (-0.92%)

16:51
09/25/18
09/25
16:51
09/25/18
16:51
Syndicate
CyrusOne 8M share Spot Secondary; price range $62.00-$64.00 »

Morgan Stanley, Deutsche…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Oct

CHGG

Chegg

$32.34

0.92 (2.93%)

16:50
09/25/18
09/25
16:50
09/25/18
16:50
Hot Stocks
Chegg says unauthorized party gained access to a company database »

On September 19, Chegg…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

EGY

VAALCO Energy

$2.59

0.14 (5.71%)

16:47
09/25/18
09/25
16:47
09/25/18
16:47
Hot Stocks
VAALCO Energy announces 10-year extension of Etame exploration area »

VAALCO Energ through its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGM

MGM Resorts

$27.86

-0.05 (-0.18%)

16:40
09/25/18
09/25
16:40
09/25/18
16:40
Options
Calls lead puts 30:1 in MGM as long call position is adjusted »

Calls lead puts 30:1 in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

NNI

Nelnet

$56.82

-0.79 (-1.37%)

16:38
09/25/18
09/25
16:38
09/25/18
16:38
Hot Stocks
Nelnet withdraws application for industrial bank charter with FDIC »

Nelnet announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:38
09/25/18
09/25
16:38
09/25/18
16:38
General news
API crude inventories for week of September 21 »

API reports that crude…

IGT

International Game

$19.91

0.23 (1.17%)

16:37
09/25/18
09/25
16:37
09/25/18
16:37
Hot Stocks
International Game partners with William Hill on U.S. lotteries »

IGT Global Solutions, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGMS

Scientific Games

$26.45

0.15 (0.57%)

16:34
09/25/18
09/25
16:34
09/25/18
16:34
Hot Stocks
Scientific Games signs contract with Hard Rock International »

Scientific Games…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGLY

Digital Ally

$3.75

-0.275 (-6.83%)

16:33
09/25/18
09/25
16:33
09/25/18
16:33
Syndicate
Digital Ally files to sell common stock, no amount given »

Roth Capital Partners is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

R

Ryder

$72.75

-0.04 (-0.05%)

16:33
09/25/18
09/25
16:33
09/25/18
16:33
Hot Stocks
Ryder CFO Art Garcia to retire in April 2019 »

Ryder announced that Art…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

BZH

Beazer Homes

$11.08

-0.015 (-0.14%)

16:33
09/25/18
09/25
16:33
09/25/18
16:33
Hot Stocks
Beazer says Hurricane Florence will result in sales, closings shifting to FY19 »

Beazer Homes provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCO

Moody's

$172.88

-2.66 (-1.52%)

16:31
09/25/18
09/25
16:31
09/25/18
16:31
Hot Stocks
Moody's appoints Mona Breed as CIO »

Moody's announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

  • 28

    Sep

  • 02

    Oct

  • 21

    Oct

FCFS

First Cash Financial

$83.03

0.625 (0.76%)

16:31
09/25/18
09/25
16:31
09/25/18
16:31
Hot Stocks
First Cash Financial announces move to Nasdaq from NYSE »

FirstCash announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 06

    Nov

OKE

Oneok

$68.44

0.565 (0.83%)

16:31
09/25/18
09/25
16:31
09/25/18
16:31
Hot Stocks
Oneok to construct additional NGL fractionation, pipeline capacity »

Oneok announced plans to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
09/25/18
09/25
16:30
09/25/18
16:30
Options
Preliminary option volume of 15.6M today »

Preliminary option volume…

MOR

MorphoSys

$27.13

0.315 (1.17%)

16:28
09/25/18
09/25
16:28
09/25/18
16:28
Hot Stocks
MorphoSys says licensee has begun study to test gselkumab in pediatric group »

MorphoSys announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NITE

Nightstar Therapeutics

$20.35

-0.97 (-4.55%)

16:26
09/25/18
09/25
16:26
09/25/18
16:26
Syndicate
Nightstar Therapeutics files to sell 4M American Depositary Shares »

Jefferies, Barclays…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

NITE

Nightstar Therapeutics

$20.35

-0.97 (-4.55%)

16:24
09/25/18
09/25
16:24
09/25/18
16:24
Syndicate
Nightstar Therapeutics files to sell 4M American Depositary Shares »

Each ADS represents one…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

VSTM

Verastem

$7.15

-1.74 (-19.57%)

16:23
09/25/18
09/25
16:23
09/25/18
16:23
Hot Stocks
Breaking Hot Stocks news story on Verastem »

Verastem rises over 5%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 05

    Oct

ICCC

Immucell

$8.35

-0.155 (-1.82%)

16:22
09/25/18
09/25
16:22
09/25/18
16:22
Hot Stocks
Immucell looks to bring mastitis treatment to market in 2020 »

ImmuCell announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

ICCC

Immucell

$8.35

-0.155 (-1.82%)

16:22
09/25/18
09/25
16:22
09/25/18
16:22
Hot Stocks
Immucell receives fourth complete letter of NADA for Nisin treatment for cows »

Immucell announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

VSTM

Verastem

$7.15

-1.74 (-19.57%)

16:21
09/25/18
09/25
16:21
09/25/18
16:21
Hot Stocks
Verastem and CSPC Pharma sign license agreement to develop COPIKTRA in China »

Verastem and CSPC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 05

    Oct

LOXO

Loxo Oncology

$166.80

3.73 (2.29%)

16:21
09/25/18
09/25
16:21
09/25/18
16:21
Hot Stocks
Loxo Oncology announces LOXO-292 durability update »

Loxo Oncology announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 26

    Nov

  • 27

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.